InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.00%
)
US TECH 100
19,204.80
(
-0.38%
)
Dow Jones
42,196.52
(
0.00%
)
Brent Oil
75.47
(
1.14%
)
Bitcoin
60,349.28
(
-0.44%
)
Post# of 253269
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: zipjet post# 59220

Monday, 02/18/2008 1:28:08 AM

Monday, February 18, 2008 1:28:08 AM

Post# of 253269
Copaxone: I think we can all agree that Copaxone is approaching $2B in W/W sales; therefore, why not apply for the 1st generic version? The drug will not disappear overnight, if at all.
Evidently, Sandoz agrees.
A poster on another Board (RPRX, naturally) mentioned that MNTA would never be able to get around Teva's patent, totally ignoring that Sanofi's Lovenox patent is, in all likelihood, being negated as we speak by Teva!




"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up